Comparison of Melphalan-Prednisone (MP) to MP Plus Thalidomide in the Treatment of Newly Diagnosed Very Elderly Patients (> 75 Years) With Multiple Myeloma

Clinical trial NCT00644306 · TERMINATED

Trial details

NCT number: NCT00644306
Sponsor: Central Hospital, Nancy, France
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Newly Diagnosed, Multiple Myeloma

Start date: 2002-04-01
Enrollment: 232

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.